<PAGE>
Exhibit (a)(10)
FOR IMMEDIATE RELEASE INVESTOR CONTACT: Donna Ackerly
Georgeson Shareholder Services Inc.
(212) 440-9837
[email protected]:[email protected]
--------------------------------------------------
PRESS CONTACT: Kimberly Cooper
(732) 906-3802
[email protected]
------------------------------
SIEMENS ANNOUNCES EARLY TERMINATION OF HART-SCOTT-RODINO WAITING PERIOD
REGARDING PENDING ACQUISITION OF ACUSON CORPORATION
NEW YORK, November 2, 2000 - Siemens Medical Engineering Group announced the
early termination of the waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended, applicable to Siemens Corporation's
pending acquisition of Acuson Corporation (NYSE: ACN).
As previously announced, Siemens Corporation and Acuson Corporation have entered
into a merger agreement pursuant to which a wholly owned subsidiary of Siemens
Corporation, Sigma Acquisition Corp., commenced on October 5, 2000, a tender
offer for all outstanding shares of common stock of Acuson Corporation at an
offer price of $23 per share, net to the seller in cash. The offer is
conditioned upon, among other things, Acuson's shareholders tendering and not
withdrawing prior to the expiration of the offer at least a majority of the
shares of Acuson's common stock. The tender offer and withdrawal rights are
scheduled to expire at 12:00 midnight, New York City time, on Thursday, November
2, 2000, unless the offer is extended.
The tender offer may be extended on the terms and conditions stated in the Offer
to Purchase, dated October 5, 2000, which is available from the information
agent for the offer: Georgeson Shareholder Communications Inc., 17 State
Street, 10th Floor, New York, New York 10004; (212) 440-9800 (bankers and
brokers); (800) 223-2064 (all others). Deutsche Banc Alex. Brown ((877) 305-
4920) is the dealer manager for the offer.
Acuson Corporation, located in Mountain View, Calif., USA, is a world-leading
provider of ultrasound systems for medical applications. In 1999, the company
posted sales of US$ 475.9 million. Acuson was founded in 1982 and is traded on
the New York Stock Exchange under the symbol ACN.
Siemens' Medical Engineering Group, headquartered in Erlangen, Germany, is one
of the largest suppliers of healthcare products and services in the world. The
Group is renowned for its innovative products, services and complete solutions,
ranging from imaging systems for diagnostics and therapy products for treatment
to electromedicine and hearing instruments to IT solutions that optimize
workflow and increase efficiency in hospitals, clinics and doctors' offices.
This release is neither an offer to purchase nor a solicitation of an offer to
sell securities of Acuson Corporation. The tender offer is being made solely by
an offer to purchase and related letter of transmittal disseminated upon the
commencement of the tender offer and amended from time to time. Shareholders of
Acuson Corporation should read the tender offer statement because it contains
important information. These documents are available to Acuson shareholders at
no charge and are also available for free at the SEC's web site
(http://www.sec.gov).
-------------------
# # #
Press releases issued are available on our web site at:
http://www.usa.siemens.com/News_and_Press/RecentPressReleases.htm
